JP2024546098A5 - - Google Patents
Info
- Publication number
- JP2024546098A5 JP2024546098A5 JP2024534019A JP2024534019A JP2024546098A5 JP 2024546098 A5 JP2024546098 A5 JP 2024546098A5 JP 2024534019 A JP2024534019 A JP 2024534019A JP 2024534019 A JP2024534019 A JP 2024534019A JP 2024546098 A5 JP2024546098 A5 JP 2024546098A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- compound according
- crystalline form
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21213418 | 2021-12-09 | ||
| EP21213418.3 | 2021-12-09 | ||
| PCT/EP2022/085060 WO2023104998A1 (en) | 2021-12-09 | 2022-12-08 | Rabeximod compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546098A JP2024546098A (ja) | 2024-12-17 |
| JP2024546098A5 true JP2024546098A5 (https=) | 2025-12-25 |
Family
ID=78827545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534019A Pending JP2024546098A (ja) | 2021-12-09 | 2022-12-08 | ラベキシモド化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11643415B1 (https=) |
| EP (1) | EP4444720A1 (https=) |
| JP (1) | JP2024546098A (https=) |
| KR (1) | KR20240115849A (https=) |
| CN (1) | CN118647618A (https=) |
| AU (1) | AU2022407139A1 (https=) |
| CA (1) | CA3239544A1 (https=) |
| WO (1) | WO2023104998A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230022880A (ko) * | 2020-06-10 | 2023-02-16 | 사익손 아베 | 라벡시모드의 결정성 형태를 포함하는 경구 제형 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE527639C2 (sv) | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
| EA201500942A1 (ru) * | 2013-03-15 | 2016-03-31 | Виронова Херпес Аб | ПРОТИВОВИРУСНЫЙ ИНДОЛО[2,3-b]ХИНОКСАЛИН |
| KR20230022880A (ko) | 2020-06-10 | 2023-02-16 | 사익손 아베 | 라벡시모드의 결정성 형태를 포함하는 경구 제형 |
-
2022
- 2022-08-19 US US17/891,462 patent/US11643415B1/en active Active
- 2022-12-08 AU AU2022407139A patent/AU2022407139A1/en active Pending
- 2022-12-08 CN CN202280081094.2A patent/CN118647618A/zh active Pending
- 2022-12-08 WO PCT/EP2022/085060 patent/WO2023104998A1/en not_active Ceased
- 2022-12-08 JP JP2024534019A patent/JP2024546098A/ja active Pending
- 2022-12-08 KR KR1020247020481A patent/KR20240115849A/ko active Pending
- 2022-12-08 CA CA3239544A patent/CA3239544A1/en active Pending
- 2022-12-08 EP EP22834585.6A patent/EP4444720A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11065237B2 (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| JP6439050B2 (ja) | Ａｓｋ１阻害剤を調製するプロセス | |
| HUP0500736A2 (hu) | A nitrogén (II)-oxid szintáz inhibitor hatású (S)-2-amino-4-(2-etánimidoilamino-etiltio)-vajsav-foszfátsó, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmény | |
| JP5305421B2 (ja) | ジアミン誘導体の製造方法 | |
| CA2550726A1 (en) | Methods of preparing aripiprazole crystalline forms | |
| TW201617319A (zh) | （２ｓ，３ｓ）７－氟－２－（４－氟苯基）－３－（１－甲基－１ｈ－１，２，４－三唑－５－基）－４－側氧基－１，２，３，４－四氫喹啉－５－羧酸甲酯之共形成體鹽及其製備方法 | |
| JPWO2014157612A1 (ja) | （１ｓ，４ｓ，５ｓ）−４−ブロモ−６−オキサビシクロ［３．２．１］オクタン−７−オンの製造方法 | |
| JP2019142893A5 (https=) | ||
| JP2024546098A5 (https=) | ||
| JP5826371B2 (ja) | ペメトレキセド塩の製造方法 | |
| WO2017106641A1 (en) | Solid state forms of brexpiprazole | |
| US20180215715A1 (en) | Solid state forms of netarsudil mesylate | |
| CN104098548B (zh) | 一种Delafloxacin的精制方法 | |
| WO2018015975A1 (en) | Amorphous solid dispersion of selexipag | |
| US8143409B2 (en) | Crystalline form of rabeprazole sodium | |
| CN107033094A (zh) | 一种药物共晶的晶型及其制备方法和组合物 | |
| US20060135565A1 (en) | Crystalline form of rabeprazole sodium | |
| CN101528696B (zh) | 晶态s-(-)-氨氯地平无水己二酸盐及其制备方法 | |
| US20240239791A1 (en) | Processes for the synthesis of valbenazine | |
| JP5357335B2 (ja) | Ｒ−７−（３−アミノメチル−４−メトキシイミノ−３−メチル−ピロリジン−１−イル）−１−シクロプロピル−６−フルオロ−４−オキソ−１，４−ジヒドロ−［１，８］ナフチリジン−３−カルボキシル酸ｌ−アスパラギン酸塩、その製造方法及びこれを含む抗菌用薬学的組成物 | |
| JP6357100B2 (ja) | ６−（ピペリジン−４−イルオキシ）−２ｈ−イソキノリン−１−オン塩酸塩の結晶性溶媒和物 | |
| KR20130039316A (ko) | １사이클로프로필８메틸７［５메틸６（메틸아미노）３피리디닐］４옥소１，４디하이드로３퀴놀린카르복실산 염 | |
| Petrova et al. | Rapid conversion of API hydrates to anhydrous forms in aqueous media | |
| JP2007217333A (ja) | 塩酸サルポグレラートの結晶形及びその製造方法 | |
| JP2014518236A (ja) | ６−（ピペリジン−４−イルオキシ）−２ｈ−イソキノリン−１−オン塩酸塩の多形体 |